Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: Relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity

Neuroscience

Volumn 161, Issue 1, 2009, Pages 23-38

  Ramos Miguel, A ^a   Garcia Fuster M J ^a   Callado, L F ^b   La Harpe, R ^c   Meana, J J ^b   Garcia Sevilla J A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Akt kinase; MAP kinases; neuroplasticity; opiate addiction; p Ser194 FADD; PEA 15; postmortem human brain

Indexed keywords

AKT1 PROTEIN; BETA ACTIN; CASEIN KINASE IALPHA; DIAMORPHINE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; METHADONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEA 15 PROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE B; SERINE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPSY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOSOL; DOWN REGULATION; GRAY MATTER; HUMAN; IMMUNODETECTION; NERVE CELL PLASTICITY; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WHITE MATTER;

ADULT; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONAL PLASTICITY; OPIOID-RELATED DISORDERS; PHOSPHOPROTEINS; PHOSPHORYLATION; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-AKT; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 67349168682     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.028     Document Type: Article

References (84)

1. Alappat E., Feig C., Boyerinas B., Volkland J., Samuels M., Murmann A.E., Thorburn A., Kidd V.J., Slaughter C.A., Osborn S.L., Winoto A., Tang W.J., and Peter M.E. Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Mol Cell 19 (2005) 321-332
2. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Höllt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol Brain Res 112 (2003) 113-125
3. Araujo H., Danziger N., Cordier J., Glowinski J., and Chneiweiss H. Chracterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem 268 (1993) 5911-5920
4. Ballesteros-Yañez I., Ambrosio E., Benavides-Piccione R., Pérez J., Torres I., Miguéns M., García-Lecumberri C., and De Felipe J. The effects of morphine self-administration on cortical pyramidal cell structure in addiction-prone Lewis rats. Cereb Cortex 17 (2007) 238-249
5. Beaulieu J.-M., Gainetdinov R.R., and Caron M.G. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28 (2007) 166-172
6. Sc-directed antibodies. J Neurochem 105 (2008) 2190-2204
7. Boumba V.A., Ziavrou K.S., and Vougiouklakis T. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25 (2006) 143-163
8. Boutros T., Chevet E., and Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60 (2008) 261-310
9. Busquets X., Escribá P.V., Sastre M., and García-Sevilla J.A. Loss of protein kinase C-αβ in brain of heroin addicts and morphine-dependent rats. J Neurochem 64 (1995) 247-252
10. Büttner A., Rohrmoser K., Mall G., Penning R., and Weis S. Widespread axonal damage in the brain of drug abusers as evidenced by accumulation of β-amyloid precursor protein (β-APP): an immunohistochemical investigation. Addiction 101 (2006) 1339-1346
11. Chinnaiyan A.M., O'Rourke K., Tewari M., and Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 (1995) 505-512
12. Christie M.J. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154 (2008) 384-396
13. Derkinderen P., Enslen H., and Girault J.-A. The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10 (1999) R24-R34
14. Derks N.M., Müller M., Gaszner B., Tilburg-Ouwenes D.T.W.M., Roubor E.W., and Kozicz L.T. Housekeeping genes revisited: different expressions depending on gender, brain area and stressor. Neuroscience 156 (2008) 305-309
15. Desbarats J., Birge R.B., Minouni-Rongy M., Weistein D.E., Palerme J.S., and Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5 (2003) 118-125
16. Escribá P.V., Sastre M., and García-Sevilla J.A. Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts. Arch Gen Psychiatry 51 (1994) 494-501
17. Everitt B.J., Hutcheson D.M., Ersche K.D., Pelloux Y., Dalley J.W., and Robbins T.W. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann N Y Acad Sci 1121 (2007) 576-597
18. Fellin T. Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J Neurochem 108 (2009) 533-544
19. Ferrer-Alcón M., La Harpe R., Guimón J., and García-Sevilla J.A. Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylation. Neuropsychopharmacology 28 (2003) 947-955
20. Ferrer-Alcón M., García-Fuster M.J., La Harpe R., and García-Sevilla J.A. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts. J Neurochem 90 (2004) 220-230
21. Formstecher E., Ramos J.W., Fauquet M., Calderwood D.A., Hsieh J.-C., Canton B., Nguyen X.-T., Barnier J.-V., Camonis J., Ginsberg M.H., and Chneiweiss H. PEA-15 mediates cytoplasmatic sequestration of ERK MAP kinase. Dev Cell 1 (2001) 239-250
22. Fuster J.M. The prefrontal cortex: an update: time is of the essence. Neuron 30 (2001) 319-333
23. García-Fuster M.J., Miralles A., and García-Sevilla J.A. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32 (2007) 399-411
24. i proteins, and ERK1/2 signaling. Neuropharmacology 55 (2008) 886-899
25. García-Fuster M.J., Ramos-Miguel A., Rivero G., La Harpe R., Meana J.J., and García-Sevilla J.A. Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience 157 (2008) 105-119
26. García-Sevilla J.A., Ventayol P., Busquets X., La Harpe R., Walzer C., and Guimón J. Regulation of immunolabelled μ-opioid receptors and protein kinase C-α and ζ isoforms in the frontal cortex of human opiate addicts. Neurosci Lett 226 (1997) 29-32
27. Gilman C.P., and Mattson M.P. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?. Neuromol Med 2 (2002) 197-213
28. Girault J.-A., Valjent E., Caboche J., and Hervé D. ERK2: a logical AND gate critical for drug-induced plasticity?. Curr Opin Pharmacol 7 (2007) 77-85
29. Glick S.D., Merski C., Steindorf S., Wang S., Keller R.W., and Carlson J.N. Neurochemical predisposition to self-administer morphine in rats. Brain Res 578 (1992) 215-220
30. Gross S.D., and Anderson R.A. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal 10 (1998) 699-711
31. Hering H., and Sheng M. Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci 2 (2001) 880-888
32. Hyman S.E. Addiction: A disease of learning and memory. Am J Psychiatry 162 (2005) 1414-1422
33. Jaffe J.H. Drug addiction and drug abuse. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed (1990), Pergamon Press, New York 522-573
34. Kalivas P.W., and O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacol Rev 33 (2008) 166-180
35. Kitsberg D., Formstecher E., Fauquet M., Kubes M., Cordier J., Canton B., Pan G.-H., Rolli M., Glowinski J., and Chneiweiss H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNF-α-induced apoptosis. J Neurosci 19 (1999) 8244-8251
36. Kuan C.-Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., and Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
37. Kuan C.-Y., Whitmarsh A.J., Yang D.D., Liao G., Schloemer A.J., Dong C., Bao J., Banasiak K.J., Haddad G.G., Flavell R.A., Davis R.J., and Rakic P. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci U S A 100 (2003) 15184-15189
38. Liao D., Lin H., Law P.Y., and Loh H.H. Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci U S A 102 (2005) 1725-1730
39. Liao D., Grigoriants O.O., Wang W., Wiens K., Loh H.H., and Law P.Y. Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci 35 (2007) 456-469
40. Linder M.C., and Goode C.A. Biochemistry of copper (1991), Plenum Press, New York
41. Lyoo I.K., Pollack M.H., Silveri M.M., Ahn K.H., Diaz C.I., Hwang J., Kim S.J., Yurgelun-Todd D.A., Kaufman M.J., and Renshaw P.F. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology 184 (2006) 139-144
42. Marie-Claire C., Courtin C., Roques B.P., and Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004) 2208-2215
43. Mattson M.P. Mitochondrial regulation of neuronal plasticity. Neurochem Res 32 (2007) 707-715
44. Mattson M.P., and Gleichmann M. The neuronal death protein Par 4 mediates dopaminergic synaptic plasticity. Mol Interv 5 (2005) 278-281
45. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., et al. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34 (2002) 807-820
46. 35S]GTPγS binding to G proteins in postmortem brains of opioid addicts. Mol Psychiatry 5 (2000) 308-315
47. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24 (2001) 167-202
48. Moghaddam B., and Homayoun H. Divergent plasticity of prefrontal cortex networks. Neuropsychopharmacol Rev 33 (2008) 42-55
49. Morón J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., and Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins. Mol Cell Proteom 6 (2007) 29-42
50. Motulsky H. Intuitive biostatistics (1995), Oxford University Press, New York
51. Muller D.L., and Unterwald E.M. In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 310 (2004) 774-782
52. Narita M., Miyatake M., Narita M., Shibasaki M., Shindo K., Nakamura A., Kuzumaki N., Nagumo Y., and Suzuki T. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 31 (2006) 2476-2488
53. Ozaita A., Escribá P.V., Ventayol P., Murga C., Mayor Jr. F., and García-Sevilla J.A. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. J Neurochem 70 (1998) 1249-1257
54. Park S.-M., Schickel R., and Peter M.E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 17 (2005) 610-616
55. Perret G., Déglon J.J., Kreek M.J., Ho A., and La Harpe R. Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998. Addiction 95 (2000) 1647-1653
56. Polakiewicz R.D., Schieferl S.M., Gingras A.-C., Sonenberg N., and Comb M.J. μ-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273 (1998) 23534-23541
57. Ramos JW (2008) Pea15. UCSD Nat Mol Pages, doi:10.1038/mp.a002536.01.
58. Ramos-Miguel A., García-Fuster M.J., Callado L.F., La Harpe R., Meana J.J., and García-Sevilla J.A. Regulation of phosphorylated forms of the proteins FADD, MAPKs, and PEA-15 in the prefrontal cotrex of human opioid abusers. Eur Neuropsychopharmacol 18 Suppl 4 (2008) S543
59. Rehm J., Frick U., Hartwig C., Gutzwiller F., Gschwend P., and Uchtenhagen A. Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug Alcoh Depend 79 (2005) 137-143
60. Reich A., Spering C., and Schulz J.B. Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity?. Trends Neurosci 31 (2008) 478-486
61. Renganathan H., Vaidyanathan H., Knapinska A., and Ramos J.W. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J 390 (2005) 729-735
62. Robinson T.E., and Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33 (1999) 160-162
63. Robinson T.E., Gorny G., Savage V.R., and Kolb B. Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46 (2002) 271-279
64. Russo S.J., Bolanos C.A., Theobald D.E., DeCarolis N.A., Renthal W., Kumar A., Winstanley C.A., Renthal N.E., Wiley M.D., Self D.W., Russell D.S., Neve R.L., Eisch A.J., and Nestler E.J. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10 (2007) 93-99
65. 2-adrenergic receptor dimers and oligomers. Biol Chem 384 (2003) 117-123
66. Sandu C., Morisawa G., Wegorzewska I., Huang T., Arechiga A.F., Hill J.M., Kim T., Walsh C.M., and Werner M.H. FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ 13 (2006) 2052-2061
67. Schoenbaum G., and Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry 63 (2008) 256-262
68. Scott F.L., Stec B., Pop C., Dobaczewska M.K., Lee J.J., Monosov E., Robinson H., Salvesen G.S., Schwarzenbacher R., and Riedl S.J. The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457 (2009) 1019-1022
69. Screaton R.A., Kiessling S., Sanson O.J., Millar C.B., Maddison K., Bird A., Clarke A.R., and Frisch S.M. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A 100 (2003) 5211-5216
70. Sharif A., Renault F., Beuvon F., Castellanos R., Canton B., Barbeito L., Junier M.P., and Chneiweiss H. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 126 (2004) 263-275
71. Sklair-Tavron L., Shi W.-X., Lane S.B., Harris H.W., Bunney B.S., and Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 93 (1996) 11202-11207
72. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9 (2005) 59-71
73. Spiga S., Serra G.P., Puddu M.C., Foddai M., and Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci 17 (2003) 605-612
74. Thomas G.M., and Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5 (2004) 173-183
75. Thomas M.J., Kalivas P.W., and Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154 (2008) 327-342
76. Trencia A., Perfetti A., Cassese A., Vigliotta G., Miele C., Oriente F., Santopietro S., Giacco F., Condorelli G., Formisano P., and Beguinot F. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol 23 (2003) 4511-4521
77. Valjent E., Corbillé A.-G., Bertran-Gonzalez J., Hervé D., and Girault J.-A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci U S A 103 (2006) 2932-2937
78. Valmiki M.G., and Ramos J.W. Death effector domain-containing proteins. Cell Mol Life Sci 66 (2009) 814-830
79. Ventayol P., Busquets X., and García-Sevilla J.A. Modulation of immunoreactive protein kinase C-α and β isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn Schmiedebergs Arch Pharmacol 355 (1997) 491-500
80. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: insights from imaging studies. J Clin Invest 111 (2003) 1444-1451
81. Weng Z., Signore A.P., Gao Y., Wang S., Zhang F., Hastings T., Yin X.-M., and Chen J. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282 (2007) 34479-34491
82. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
83. Zhang J., Zhang D., and Hua Z. FADD and its phosphorylation. IUBMB Life 56 (2004) 395-401
84. Zuliani C., Kleber S., Klussmann S., Wenger T., Kenzelmann M., Schreglmann N., Martínez A., del Río J.A., Soriano E., Vodrazka P., Kuner R., Groene H.J., Herr I., Krammer P.H., and Marín-Villalba A. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13 (2006) 31-40